Does TOCILIZUMAB Cause Therapy partial responder? 208 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 208 reports of Therapy partial responder have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.2% of all adverse event reports for TOCILIZUMAB.
208
Reports of Therapy partial responder with TOCILIZUMAB
0.2%
of all TOCILIZUMAB reports
3
Deaths
19
Hospitalizations
How Dangerous Is Therapy partial responder From TOCILIZUMAB?
Of the 208 reports, 3 (1.4%) resulted in death, 19 (9.1%) required hospitalization, and 6 (2.9%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 208 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which TOCILIZUMAB Alternatives Have Lower Therapy partial responder Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE